Conversion to a sirolimus‐based regimen is associated with lower incidence of <scp>BK</scp> viremia in low‐risk kidney transplant recipients

Abstract

Conversion to Sir-based maintenance immunosuppression at or about 3 months after kidney transplantation correlates with a lower incidence of BK viremia.